Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Group 1 - Absci Corporation will report its business updates and financial results for Q4 and full year 2025 on March 24, 2026, after market close [1] - A conference call will be held at 4:30 p.m. Eastern Time to discuss the results and outlook, with a live audio webcast available on the company's investor relations website [2] - Absci is focused on drug discovery using generative design, aiming to create better biologics more rapidly through its Integrated Drug Creation™ platform [3] Group 2 - The company is advancing its pipeline of AI-designed therapeutics, including ABS-201™, which targets hair regrowth and has potential applications for endometriosis [3] - Absci's approach involves a continuous feedback loop between AI algorithms and wet lab validation, enhancing the precision of therapeutic designs [3] - The company has established collaborations with leading pharmaceutical, biotech, tech, and academic organizations to further its drug development efforts [3]